Immunotherapy and chemotherapy — a practical partnership
Generate an AI Snapshot to get a quick, structured summary of this paper.
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
How recent data have altered the way the authors understand how dying tumour cells, particularly those killed by chemotherapy, engage with antitumour immune responses has significant implications for the development of new protocols combining chemotherapy with immunotherapy.
Abstract
This article discusses how recent data have altered the way we understand how dying tumour cells, particularly those killed by chemotherapy, engage with antitumour immune responses. These data have significant implications for the development of new protocols combining chemotherapy with immunotherapy, indicating an exciting potential for therapeutic synergy with general applicability to many cancer types.
